Park Joonseon, An Solji, Bae Ja Seong, Kim Kwangsoon, Kim Jeong Soo
Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
Cancers (Basel). 2024 Jul 18;16(14):2577. doi: 10.3390/cancers16142577.
The prognostic significance of tumor size in T3b differentiated thyroid cancer (DTC) remains debated and underexplored. This study aimed to examine the varying impact of T3b based on tumor size, analyzing disease-specific survival, disease-free survival, and overall survival. A retrospective review of 6282 DTC patients who underwent thyroid surgery at Seoul St. Mary's Hospital from September 2000 to December 2017 was conducted. T3b was classified into three subcategories, T3b-1 (≤2 cm), T3b-2 (2-4 cm), and T3b-3 (>4 cm), using the same size criteria for T1, T2, and T3a. T3b-1 showed no significant difference in disease specific survival compared to T1, and both disease-free and disease-specific survival curves were sequentially ranked as T1, T3b-1, T2, T3a, T3b-2, and T3b-3. The modified T category, reclassifying T3b-1 as T1, demonstrated superior staging performance compared to the classic T category (c-index: 0.8961 vs. 0.8959 and AUC: 0.8573 vs. 0.8518). Tumors measuring 2 cm or less within the T3b category may require downstaging, and a modified T category could improve the precision of prognostic staging compared to the current T category.
肿瘤大小在T3b期分化型甲状腺癌(DTC)中的预后意义仍存在争议且未得到充分研究。本研究旨在根据肿瘤大小研究T3b期的不同影响,分析疾病特异性生存、无病生存和总生存情况。对2000年9月至2017年12月在首尔圣玛丽医院接受甲状腺手术的6282例DTC患者进行了回顾性研究。使用与T1、T2和T3a相同的大小标准,将T3b分为三个亚类,即T3b-1(≤2 cm)、T3b-2(2-4 cm)和T3b-3(>4 cm)。与T1相比,T3b-1在疾病特异性生存方面无显著差异,无病生存曲线和疾病特异性生存曲线依次排序为T1、T3b-1、T2、T3a、T3b-2和T3b-3。将T3b-1重新分类为T1的改良T分类法,与经典T分类法相比,显示出更好的分期性能(c指数:0.8961对0.8959;AUC:0.8573对0.8518)。T3b期内直径2 cm或更小的肿瘤可能需要降期,与当前的T分类法相比,改良T分类法可提高预后分期的准确性。